Bone mineral density screening should be routine in lymphoma patients
Ann Oncol
.
2014 Apr;25(4):913-914.
doi: 10.1093/annonc/mdu044.
Authors
M A Thompson
1
,
J R Westin
2
,
F B Hagemeister
2
Affiliations
1
Aurora Research Institute, Aurora Health Care, Milwaukee. Electronic address:
[email protected]
.
2
Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
PMID:
24667725
DOI:
10.1093/annonc/mdu044
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Antineoplastic Agents / therapeutic use*
Bone Resorption / blood*
Female
Humans
Lymphoma / drug therapy*
Male
Substances
Antineoplastic Agents